Abstract
Objective: To evaluate the efficacy of intermittent clobazam therapy in preventing the recurrence of febrile seizures and to assess its safety.Methods: The study was a prospective, randomized, double-blind placebo-controlled trial conducted in the Department of Child Health, Christian Medical College Hospital, Vellore between July 2001 and September 2002. Neurologically normal children between 6 months and 3 years of age with a history of febrile seizures and no evidence of acute CNS infection or EEG abnormality were included into the study. 19 children in a clobazam group and 20 in the placebo group were randomly allocated. Temperature reduction measures with paractamol and tepid sponging were advised to all children. In addition the dispensed medication was to be administered at the onset of fever and continued for 48 hours irrespective of the duration of fever. The children were then monitored for seizures and adverse effects of clobazam. The children were followed up for a mean period of 9.9 months. The analysis was done on the number of febrile episodes in both the groups.Results: There were a total of 110 episodes of fever during the study period. Mean number of febrile episodes in the clobazam group was 3.1 and in placebo group 2.56. Six (12.5%) of the 48 episodes in placebo group and one (1.7%) of 60 episodes in clobazam group had seizure recurrence. This was statistically significant (p=0.01). Drowsiness and weakness were present equally in both clobazam and placebo group whereas ataxia was present only in the clobazam group, the difference being statistically significant (p=0.04).Conclusion: Intermittent clobazam therapy is an effective measure in the prevention of recurrence of febrile seizures. The ataxia due to clobazam was much lower than that reported with diazepam.
Similar content being viewed by others
References
Hirtz DG. Generalized tonic clonic and febrile seizures.Pediatr Cli North Am 1989; 36: 375–382.
Nelson’s Texbook of Pediatrics. 16th edn. Vol 1 page 1818–1819
Nelson KB, Ellenberg JH. Prognosis in children with febrile seizures.Pediatrics 1978; 61: 720–727.
Thilothamaml Net al. Role of phenobarbitone in preventing recurrent febrile convulsions.Indian Pediatr 1993; 30: 637–642.
Wallace SJ, Smith JA. Successful prophylaxis against febrile convulsions with Valporic acid or phenobarbitone.Brit Med J 1980; 280: 353–354.
Rosman NP, Colton T, Labazzo Jet al. A controlled trial of diazepam administered during febrile illness to prevent recurrence of febrile seizures.N Engl J Med 1993; 329: 79–84.
Goodman and Gillman.The Pahrmacological Basis of Therapeutics. pp 362–373.
Steru L, Chermat R, Millet B, Nico A, Simon P. Comparative study in mice of ten 1,4 benzodiazepines and clobazam. Anticonvulsant, Anxiolytic, Sedative and Myorelaxant Effects.Epilepsia 1986; 27: 14–27.
Scott DE, Moffet A. The long term effect of clobazam as adjunctive therapy in epilepsy.Acta Neurol Scand 1988; 498–502.
Knudsen FU, Vestermark S. Prophylactic diazepam or phenobabitone in febrile convulsions: a prospective controlled study.Arch Dis Child 1978; 53: 660–663.
Maria Luizaet al. Treatment of febrile seizures with intermittent clobazam.Arq Neuropsiquiatr 1997; 55(4): 757–761.
Berg AT, Shinnar S, Houser WAet al. A prospective study of recurrent febrile seizures.New Engl J Med 1992; 327: 1122–1127.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rose, W., Kirubakaran, C. & Scott, J.X. Intermittent clobazam therapy in febrile seizures. Indian J Pediatr 72, 31–33 (2005). https://doi.org/10.1007/BF02760577
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02760577